Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

by Wolfgang M. Brueckl, Joachim H. Ficker, Gloria Zeitler
Published 2020-12-01

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

by Jakob M. Riedl, Dominik A. Barth, Wolfgang M. Brueckl, Gloria Zeitler, Vasile Foris, Stefanie Mollnar, Michael Stotz, Christopher H. Rossmann, Angelika Terbuch, Marija Balic, Tobias Niedrist, Thomas Bertsch, Herbert Stoeger, Martin Pichler, Horst Olschewski, Gudrun Absenger, Joachim H. Ficker, Armin Gerger, Florian Posch
Published 2020-08-01